135 related articles for article (PubMed ID: 32404846)
1. The Concept of Minimal Residual Disease in the Treatment and Staging of Vitreoretinal Lymphoma.
Stacey AW; Pulido JS
Retina; 2020 Jul; 40(7):1213-1214. PubMed ID: 32404846
[No Abstract] [Full Text] [Related]
2. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
Rajagopal R; Harbour JW
Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
[TBL] [Abstract][Full Text] [Related]
3. Perivascular tumour balls in primary vitreoretinal lymphoma.
Takkar B; Rathi A; Gaur N; Kumar A
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567275
[No Abstract] [Full Text] [Related]
4. The challenge in the diagnosis and management of vitreoretinal lymphoma.
Habot-Wilner Z; Pe'er J; Frenkel S
Clin Exp Ophthalmol; 2023 Mar; 51(2):107-109. PubMed ID: 36789671
[No Abstract] [Full Text] [Related]
5. [Ⅳ. Advances in Diagnosis and Treatment of Vitreoretinal Lymphoma].
Taoka K
Gan To Kagaku Ryoho; 2023 May; 50(5):605-610. PubMed ID: 37218321
[No Abstract] [Full Text] [Related]
6. Controversies in intraocular lymphoma.
Wakefield D; Zierhut M
Ocul Immunol Inflamm; 2009; 17(1):4-5. PubMed ID: 19294565
[No Abstract] [Full Text] [Related]
7. Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis.
Tan WJ; Wang MM; Ricciardi-Castagnoli P; Tang T; Chee SP; Lim TS; Chan ASY
Blood; 2019 Aug; 134(8):709-712. PubMed ID: 31292111
[No Abstract] [Full Text] [Related]
8. Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma.
Kakkassery V; Schroers R; Coupland SE; Wunderlich MI; Schargus M; Heinz C; Wasmuth S; Heiligenhaus A; Ahle G; Lenoble P; Schlegel U; Schmiegel W; Dick HB; Baraniskin A
Blood; 2017 Jun; 129(23):3130-3133. PubMed ID: 28389463
[No Abstract] [Full Text] [Related]
9. Diffuse large B-cell lymphoma in immunoprivileged sites: association of vitreoretinal, testicular and central nervous system lymphoma.
Riemens A; Missotten T; Baarsma S; Vidovic-Valentincic N; Novac-Andrejcic K; Erckens R; Kuijpers R; Lokhorst H; Rothova A
Acta Ophthalmol; 2014 Mar; 92(2):e159-60. PubMed ID: 23819861
[No Abstract] [Full Text] [Related]
10. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
11. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
12. Primary intraocular lymphoma in a patient with systemic lupus erythematosus.
Woei-A-Jin FJ; Kersting S; Bollemeijer JG
Ann Hematol; 2012 Nov; 91(11):1821-2. PubMed ID: 22552607
[No Abstract] [Full Text] [Related]
13. Who Is Who in Primary Vitreoretinal Lymphoma?
Ferreri AJ
JAMA Oncol; 2015 Oct; 1(7):977-8. PubMed ID: 26181757
[No Abstract] [Full Text] [Related]
14. Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral Lymphoma (LOC) Network (clinical trial number: NCT02542514).
Soussain C; Malaise D; Choquet S; Ghesquières H; Houillier C
Eur J Cancer; 2023 Aug; 189():112909. PubMed ID: 37301714
[No Abstract] [Full Text] [Related]
15. Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma.
Baron M; Belin L; Cassoux N; Fardeau C; Blaizeau M; Soussain C; Houillier C; Hoang-Xuan K; Gyan E; Le Lez ML; Lavaud A; Soubeyran P; Bodaghi B; Costopoulos M; Leblond V; Touitou V; Maloum K; Errera MH; Roos-Weil D; Le Garff-Tavernier M; Choquet S
Blood; 2020 May; 135(20):1811-1815. PubMed ID: 32125361
[No Abstract] [Full Text] [Related]
16. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma.
Pulido JS; Salomao DR; Frederick LA; Viswanatha DS
Retina; 2015 Apr; 35(4):624-7. PubMed ID: 25768255
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of primary vitreoretinal lymphoma developing extra-central nervous system (CNS)/testicular lymphomas with or without CNS involvement: A single-centre study of 13 cases.
Kunimi K; Usui Y; Sugawara R; Asakage M; Tsubota K; Gotoh A; Goto H
Br J Haematol; 2023 Apr; 201(1):158-161. PubMed ID: 36693806
[No Abstract] [Full Text] [Related]
18. Refractory Primary Vitreoretinal Lymphoma Involving the Spinal Cord with a Temporary Complete Response to Tirabrutinib.
Iizuka-Honma H; Takizawa H; Mitsumori T; Okura H; Ishii H; Noguchi M
Intern Med; 2023 Feb; 62(3):459-463. PubMed ID: 35793963
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D
Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016
[No Abstract] [Full Text] [Related]
20. Intraocular lymphoma: more questions than answers.
Wakefield D; Zierhut M
Ocul Immunol Inflamm; 2009; 17(1):6-10. PubMed ID: 19294566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
